A clinical trial of MK-1045 in people with B-cell acute lymphoblastic leukemia (MK-1045-005)

Trial Identifier: 1045-005
Sponsor: MSD
Start Date: May 2026
Primary Completion Date: October 2033
Study Completion Date: October 2033
Condition: Leukemia

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
Protocol Plain Language Summary

Trial Locations

Country Location
Israel, N/A Haifa, N/A, Israel, 3109601
Israel, N/A Jerusalem, N/A, Israel, 9112001
Israel, N/A Ramat Gan, N/A, Israel, 5265601
Japan, Tokyo Bunkyo, Tokyo, Japan, 113-8677
Spain, Madrid Madrid, Spain, 28233